NCT05334706 2026-02-23
RIFT-HPV
Institut d'Investigació Biomèdica de Bellvitge
Phase 4 Recruiting
Clinical Trials
29 trialsNCT04206813 2026-01-27
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Boston Medical Center
Phase 4 Active not recruiting
NCT04474821 2026-01-12
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
Mayo Clinic
Phase 4 Completed
NCT06538480 2025-12-15
Zopa Retreatment and Vector Shedding in Adults With RRP
Precigen, Inc
Phase 4 Recruiting
NCT07281677 2025-12-15
Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years
Zhejiang Provincial Center for Disease Control and Prevention
Phase 4 Recruiting
NCT05672927 2025-10-06
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
The University of Texas Medical Branch, Galveston
Phase 4 Recruiting
NCT04953130 2025-09-10
Add-Vacc
London School of Hygiene and Tropical Medicine
Phase 4 Active not recruiting
NCT03180034 2025-09-04
ESCUDDO
National Cancer Institute (NCI)
Phase 4 Active not recruiting
NCT04982614 2025-08-24
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
Columbia University
Phase 4 Completed
NCT05266898 2025-04-18
AGO-Gard
Louisiana State University Health Sciences Center in New Orleans
Phase 4 Recruiting
NCT05291871 2025-03-27
Immunogenicity of Fractional Dose of the HPV Vaccines
University of Washington
Phase 4 Active not recruiting
NCT01824537 2025-03-19
TRAP-HPV
McGill University
Phase 4 Completed
NCT04270773 2024-07-10
9-VPH-MVIH
University Hospital Virgen de las Nieves
Phase 4 Active not recruiting
NCT05439083 2024-03-08
Immunogenicity of 9-valent HPV Vaccine
Instituto de Investigación Hospital Universitario La Paz
Phase 4 Recruiting
NCT04590521 2024-02-01
HPV Vaccine Immunity in High-risk Women
Murdoch Childrens Research Institute
Phase 4 Completed
NCT03675256 2023-12-13
The KEN SHE Study on HPV-vaccine Efficacy
Massachusetts General Hospital
Phase 4 Unknown
NCT05435209 2023-11-29
Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents
University of Washington
Phase 4 Completed
NCT05863975 2023-05-18
Treatment of HPV Infection in Perimenopausal and Postmenopausal Women
Qianfoshan Hospital
Phase 4 Unknown
NCT05808816 2023-04-11
"Lactobacillus Crispatus M247, LSIL and Microbiota"
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4 Unknown
NCT05426148 2022-06-29
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
Xiamen Innovax Biotech Co., Ltd
Phase 4 Completed
NCT04459221 2022-03-02
PROM SSCOL
Centre Hospitalier Universitaire de la Réunion
Phase 4 Completed
NCT04910802 2021-09-16
Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
Region Stockholm
Phase 4 Recruiting
NCT01101750 2021-01-05
Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
Medstar Health Research Institute
Phase 4 Completed
NCT00956553 2020-10-01
HPV CSP01
Public Health England
Phase 4 Completed
NCT01031069 2020-07-21
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
GlaxoSmithKline
Phase 4 Completed
NCT00534638 2019-11-15
Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents
GlaxoSmithKline
Phase 4 Completed
NCT00925288 2012-10-11
Girasol
Johns Hopkins Bloomberg School of Public Health
Phase 4 Completed
NCT01571141 2012-04-19
Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection
AGUNCO Obstetrics and Gynecology Centre
Phase 4 Completed
NCT01082861 2010-03-19
TANGO
National Institute for Public Health and the Environment (RIVM)
Phase 4 Terminated